Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9082275 | 0.98 | CYP4F2 (0.32) | CYP4F2CYP4A11DAO | |
| SCHEMBL2005497 | 0.92 | — | — | |
| SCHEMBL28396262 | 0.89 | L3MBTL1 (0.34) | — | |
| Methylamine SCHEMBL28311613 | 0.86 | KDM4E (0.32) | — | |
| SCHEMBL5603669 | 0.80 | KCNH2 (0.47) | LMNACYP3A4 | |
| SCHEMBL3823108 | 0.80 | CA12 (0.31) | CA2 | |
| SCHEMBL28690250 | 0.80 | HRH1 (0.43) | MAOA | |
| SCHEMBL3021563 | 0.80 | — | — | |
| SCHEMBL16196855 | 0.80 | KCNH2 (0.47) | LMNACYP3A4 | |
| SCHEMBL28696596 | 0.80 | HRH1 (0.43) | MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090297454-A1 | Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use | SCHIRMER HEIKO | 2009-12-03 | — | — | US | disclosed |
| US-7618957-B2 | 1-N-(Benzyloxycarbonyl)-1H,1H,2H,2H,4H,4H,5H,5H-3-aza-perfluorotridecylamine; used in NMR and x-ray diagnosis, radiodiagnosis, and radiotherapy, as well as in MRT lymphography and in blood-pool imaging | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-11-17 | — | — | US | disclosed |
| US-20070189969-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070020183-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-25 | — | — | US | disclosed |
| CN-1191072-A | Lawn growth regulator | WANG XIANFA (CN) | 1998-08-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020183-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | AFF1, FRG1, AFF2 | LMNA 2326/4885PGR 143/4885CYP3A4 1059/4885 |
| US-20070189969-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | AFF1, FGB, PF4 | LMNA 2071/4885PGR 145/4885CYP3A4 961/4885 |
| US-20090297454-A1 | Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use | AFF1, FGB, PF4 | LMNA 2071/4885PGR 145/4885CYP3A4 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.